Incentives to Promote Medication Adherence Among HIV-Infected Youth
Completed
Conditions studied: HIV
In brief
Medication adherence is one of the most salient predictors of patient outcomes in the era following development of effective treatment for HIV infection. Evolving strategies to improve adherence, specifically incentive interventions and real-time medication monitoring, have shown some success in limited studies. Further investigation into incentive interventions for HIV-infected adolescents with poor medication adherence is necessary.
Key facts
- Study ID
- NCT02206906
- Run by
- St. Jude Children's Research Hospital
- People needed
- 25
- Starts
- 2014-07-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2016-06-21
Who can join
Age: 16 and older, up to 24. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥16 and ≤ 24 years old
- Documented diagnosis of HIV
- Adolescent is aware of his/her HIV diagnosis
- Adolescent understands either written or spoken English.
- Adolescent is willing and able to provide informed consent or assent.
- Adolescent has access to a phone and the internet at the time of enrollment.
- Adolescent meets the definition of inadequate ARV adherence, which is any of the following in the previous 12 months:
- < 80% adherent to any ARV by pharmacy pill count
- ≥ 7 days delay in scheduled ARV prescription pick-up
- Detectable viral load after being on ARVs for at least 12 weeks
You may not qualify if…
- Adolescent has a documented diagnosis of mental retardation or a significant motor or sensory impairment that would preclude participation.
- Adolescent has a documented acute psychiatric illness, including suicidal ideation, homicidal ideation or active psychosis.
- Adolescent was diagnosed with HIV in the previous 6 months.
- Adolescent has a planned transition to alternative care setting prior to study completion (e.g. relocation, pregnancy or planned pregnancy, transition to adult care).
- Concurrent enrollment on a research study with an intervention targeted at increasing adherence to antiretroviral regimens.
Where it is running
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.